Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.94B | 2.77B | 2.63B | 2.51B | 2.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.94B | 2.77B | 2.63B | 2.51B | 2.52B |
| Cost of Revenue | 938.87M | 900.36M | 924.71M | 941.98M | 934.31M |
| Gross Profit | 2.00B | 1.87B | 1.70B | 1.57B | 1.59B |
| SG&A Expenses | 1.14B | 1.08B | 1.04B | 974.72M | 977.48M |
| Depreciation & Amortization | 118.19M | 118.75M | 118.98M | 118.50M | 119.37M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.34B | 2.25B | 2.22B | 2.17B | 2.19B |
| Operating Income | 599.75M | 523.41M | 403.12M | 336.82M | 326.60M |
| Income Before Tax | 605.07M | 460.50M | 373.54M | 232.95M | 120.72M |
| Income Tax Expenses | 67.20M | 36.72M | 16.89M | 47.39M | 17.74M |
| Earnings from Continuing Operations | 537.87 | 423.78 | 356.65 | 185.56 | 102.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 537.87M | 423.78M | 356.65M | 185.56M | 102.98M |
| EBIT | 599.75M | 523.41M | 403.12M | 336.82M | 326.60M |
| EBITDA | 876.59M | 798.48M | 674.13M | 600.95M | 579.99M |
| EPS Basic | 3.98 | 3.13 | 2.63 | 1.36 | 0.76 |
| Normalized Basic EPS | 2.81 | 2.30 | 1.77 | 1.44 | 1.30 |
| EPS Diluted | 3.93 | 3.10 | 2.60 | 1.34 | 0.75 |
| Normalized Diluted EPS | 2.78 | 2.27 | 1.74 | 1.42 | 1.28 |
| Average Basic Shares Outstanding | 540.88M | 543.19M | 544.31M | 544.30M | 542.90M |
| Average Diluted Shares Outstanding | 548.24M | 551.38M | 554.05M | 554.53M | 550.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |